Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parks, E. J., & Hellerstein, M. K. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.412 · Cited by 530
Regulation of Hepatic De Novo Lipogenesis in Humans
Hellerstein, M. K., Schwarz, J.-M., & Neese, R. A. (1996) · Annual Review of Nutrition · doi:10.1146/annurev.nu.16.070196.002515 · Cited by 349 · cited 4×
“The selected ion-monitoring mode was used and the fractional de novo synthesis was calculated as described in detail previously (17).”
BackgroundMethodInfluentialFat and carbohydrate overfeeding in humans: different effects on energy storage
Horton, T., Drougas, H., Brachey, A., Reed, G., Peters, J., & Hill, J. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.1.19 · Cited by 339 · cited 3×
“It is known that dietary carbohydrate promotes its own oxidation (9, 13, 32) and that under normal conditions DNL is not a major way to increase body fat stores, as found by other investigators using indirect calorimetry (20, 31).”
BackgroundResultAarsland, A., Chinkes, D., & Wolfe, R. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119005 · Cited by 212
Cited by
Lambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069
Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications
Carta, G., Murru, E., Banni, S., & Manca, C. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00902 · Cited by 809
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
Smith, G. I., Shankaran, M., Yoshino, M., Schweitzer, G. G., Chondronikola, M., Beals, J. W., Okunade, A. L., Patterson, B. W., Nyangau, E., Field, T., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134165 · Cited by 771
Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease
Softic, S., Cohen, D. E., & Kahn, C. R. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4054-0 · Cited by 709
“However, these initial studies were performed under fasting conditions, when lipid synthesis is at a nadir [41, 42] and on lean subjects who have much lower rates of lipogenesis than obese and insulin-resistant patients [43].”
BackgroundAMPK as a Therapeutic Target for Treating Metabolic Diseases
Day, E. A., Ford, R. J., & Steinberg, G. R. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.05.004 · Cited by 619
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
Saponaro, C., Gaggini, M., Carli, F., & Gastaldelli, A. (2015) · Nutrients · doi:10.3390/nu7115475 · Cited by 529
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Taskinen, M.-R., & Borén, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.039 · Cited by 440
Mozaffarian, D., Cao, H., King, I. B., Lemaitre, R. N., Song, X., Siscovick, D. S., & Hotamisligil, G. S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-12-201012210-00005 · Cited by 363
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
Pafili, K., & Roden, M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101122 · Cited by 330
The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state
Hodson, L., & Gunn, P. J. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0256-9 · Cited by 309
Dietary carbohydrates and fats in nonalcoholic fatty liver disease
Yki-Järvinen, H., Luukkonen, P. K., Hodson, L., & Moore, J. B. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00472-y · Cited by 294
Higher Protein Intake Preserves Lean Mass and Satiety with Weight Loss in Pre‐obese and Obese Women
Leidy, H. J., Carnell, N. S., Mattes, R. D., & Campbell, W. W. (2007) · Obesity · doi:10.1038/oby.2007.531 · Cited by 277
Sanders, F. W. B., Acharjee, A., Walker, C., Marney, L., Roberts, L. D., Imamura, F., Jenkins, B., Case, J., Ray, S., Virtue, S., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1439-8 · Cited by 114
Volk, B. M., Kunces, L. J., Freidenreich, D. J., Kupchak, B. R., Saenz, C., Artistizabal, J. C., Fernandez, M. L., Bruno, R. S., Maresh, C. M., Kraemer, W. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113605 · Cited by 112
“De novo lipogenesis (DNL) increases several-fold when carbohydrate is fed above energy needs [3], but isocaloric high-carbohydrate diets [4] and highcarbohydrate meals [5, 6] also promote DNL and hypertriglyceridemia in individuals with insulin resistance.”
BackgroundLabayen, I., Dı́ez, N., Parra, D., González, A., & Martı́nez, J. A. (2004) · Clinical Nutrition · doi:10.1016/j.clnu.2003.10.004 · Cited by 83
Self-citationCharidemou, E., Ashmore, T., Li, X., McNally, B. D., West, J. A., Liggi, S., Harvey, M., Orford, E., & Griffin, J. L. (2019) · JCI Insight · doi:10.1172/jci.insight.124819 · Cited by 52
“It has previously been established that hyperinsulinemia and high carbohydrate diets “prime” DNL by providing a large substrate pool (5, 6).”
BackgroundZhu, Z., Zhang, X., Pan, Q., Zhang, L., & Chai, J. (2023) · Liver Research · doi:10.1016/j.livres.2023.11.003 · Cited by 38
Mursu, J., Virtanen, J. K., Rissanen, T. H., Tuomainen, T.-P., Nykänen, I., Laukkanen, J. A., Kortelainen, R., & Voutilainen, S. (2011) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.08.001 · Cited by 34
“In obese [15] and possibly physically inactive [16], because of underlying insulin resistance and other related metabolic disturbances, these deleterious physiological changes may be exacerbated.”
Background
Metadata
- Authors
- Marques-Lopes, I., Ansorena, D., Astiasaran, I., Forga, L., & Martínez, J. A.
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2001-02
- Volume
- 73
- Issue
- 2
- Pages
- 253-261
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W1934420673
- Cited by
- 159
- References
- 4
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.